Literature DB >> 28660310

Advanced glycation endproducts induce self- and cross-tolerance in monocytes.

Florian Uhle1, Sebastian Weiterer2, Benedikt Hermann Siegler2, Thorsten Brenner2, Christoph Lichtenstern2, Markus Alexander Weigand2.   

Abstract

INTRODUCTION: Advanced glycation endproducts (AGEs) are well-known inflammatory mediators, which are recognized by immune cells through their corresponding receptor RAGE and have been shown to participate in the pathophysiology of a variety of acute as well as chronic inflammatory diseases. Nevertheless, no data are available on the aftermath of AGE recognition on immune cells.
MATERIALS AND METHODS: We used the monocytic cell line MonoMac6 as well as primary human monocytes for double stimulation experiments. We measured secreted as well as intracellular levels of TNF-α using ELISA and flow cytometry. In addition, gene expression of surface receptors (RAGE and TLR4) and TNF were measured by qPCR.
RESULTS: Stimulation with AGE leads to a dose-dependent induction of self- and cross-tolerance in both primary monocytes as well as the MonoMac6 cell line. The AGE tolerance depended neither on a decreased expression of RAGE or TLR4, nor on a decrease of TNF-α expression. Nevertheless, intracellular TNF-α was decreased, hinting towards a posttranscriptional regulation.
CONCLUSION: High levels of AGEs are capable to activate immune cells at first, but induce a secondary state of hypo-responsiveness in these cells. Based on the origin of its causal agent, we propose this phenomenon to be "metabolic tolerance".

Entities:  

Keywords:  AGE; Inflammation; Methylglyoxal; SIRS; Sepsis

Mesh:

Substances:

Year:  2017        PMID: 28660310     DOI: 10.1007/s00011-017-1076-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  31 in total

Review 1.  MicroRNAs: the fine-tuners of Toll-like receptor signalling.

Authors:  Luke A O'Neill; Frederick J Sheedy; Claire E McCoy
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

2.  Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products.

Authors:  J Li; A M Schmidt
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

3.  Burn trauma induces early HMGB1 release in patients: its correlation with cytokines.

Authors:  János Lantos; Viktor Földi; Elizabeth Roth; György Wéber; Lajos Bogár; Csaba Csontos
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

Review 4.  Cellular signalling of the receptor for advanced glycation end products (RAGE).

Authors:  Jianling Xie; José D Méndez; Verna Méndez-Valenzuela; María Montserrat Aguilar-Hernández
Journal:  Cell Signal       Date:  2013-07-06       Impact factor: 4.315

5.  Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells.

Authors:  Rajesh Aneja; Kelli Odoms; Katherine Dunsmore; Thomas P Shanley; Hector R Wong
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 6.  The receptor for advanced glycation end products (RAGE) and the lung.

Authors:  Stephen T Buckley; Carsten Ehrhardt
Journal:  J Biomed Biotechnol       Date:  2010-01-19

7.  Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance.

Authors:  Rajesh K Aneja; Allan Tsung; Hanna Sjodin; Julia V Gefter; Russell L Delude; Timothy R Billiar; Mitchell P Fink
Journal:  J Leukoc Biol       Date:  2008-08-07       Impact factor: 4.962

8.  Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance.

Authors:  Mohamed El Gazzar; Barbara K Yoza; Jean Y-Q Hu; Sue L Cousart; Charles E McCall
Journal:  J Biol Chem       Date:  2007-07-23       Impact factor: 5.157

Review 9.  Immunosuppression following surgical and traumatic injury.

Authors:  Fumio Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Masayuki Ohtsuka; Masaru Miyazaki
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

Review 10.  Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences.

Authors:  Eduardo López-Collazo; Carlos del Fresno
Journal:  Crit Care       Date:  2013-11-14       Impact factor: 9.097

View more
  1 in total

1.  Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages.

Authors:  Atsuhiro Kitaura; Takashi Nishinaka; Shinichi Hamasaki; Omer Faruk Hatipoglu; Hidenori Wake; Masahiro Nishibori; Shuji Mori; Shinichi Nakao; Hideo Takahashi
Journal:  PLoS One       Date:  2021-01-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.